CD55 was also significantly down regulated (P < 0.05) with approximately 3.8 fold in AML and ALL patients suggesting the possibility that cancer may evade complement attack mechanism and may even manipulate it to its benefit. Here, CD55 is linked to acute lymphoblastic leukemia.